These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 26605513)
1. CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma. Hoffmann C; Schommers P; Wolf E; Müller M; Schultze A; Krznaric I; Stoehr A; Wolf T; Fäktenheuer G; Stier B; Wyen C; Hentrich M AIDS; 2016 Mar; 30(5):753-60. PubMed ID: 26605513 [TBL] [Abstract][Full Text] [Related]
2. Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study. Hoffmann C; Hentrich M; Gillor D; Behrens G; Jensen B; Stoehr A; Esser S; van Lunzen J; Krznaric I; Müller M; Oette M; Hensel M; Thoden J; Fätkenheuer G; Wyen C HIV Med; 2015 Apr; 16(4):261-4. PubMed ID: 25252101 [TBL] [Abstract][Full Text] [Related]
3. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma. Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895 [TBL] [Abstract][Full Text] [Related]
4. Assessment of immunovirological features in HIV related non-Hodgkin lymphoma patients and their impact on outcome. Tedeschi R; Bortolin MT; Bidoli E; Zanussi S; Pratesi C; Vaccher E; Tirelli U; De Paoli P J Clin Virol; 2012 Apr; 53(4):297-301. PubMed ID: 22244256 [TBL] [Abstract][Full Text] [Related]
5. Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy. Bibas M; Trotta MP; Cozzi-Lepri A; Lorenzini P; Pinnetti C; Rizzardini G; Angarano G; Caramello P; Sighinolfi L; Mastroianni CM; Mazzarello G; Di Caro A; Di Giacomo C; d'Arminio Monforte A; Antinori A; Am J Hematol; 2012 Aug; 87(8):749-53. PubMed ID: 22718364 [TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy. Gotti D; Danesi M; Calabresi A; Ferraresi A; Albini L; Donato F; Castelli F; Scalzini A; Quiros-Roldan E; AIDS Patient Care STDS; 2013 May; 27(5):259-65. PubMed ID: 23600703 [TBL] [Abstract][Full Text] [Related]
7. Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma. Piriou E; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D Blood; 2005 Nov; 106(9):3166-74. PubMed ID: 16014568 [TBL] [Abstract][Full Text] [Related]
8. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia. Hudnall SD; Betancourt E; Barnhart E; Patel J Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945 [TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Polesel J; Clifford GM; Rickenbach M; Dal Maso L; Battegay M; Bouchardy C; Furrer H; Hasse B; Levi F; Probst-Hensch NM; Schmid P; Franceschi S; AIDS; 2008 Jan; 22(2):301-6. PubMed ID: 18097233 [TBL] [Abstract][Full Text] [Related]
10. HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes. Bohlius J; Schmidlin K; Boué F; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Paparizos V; Miro JM; Obel N; Prins M; Chêne G; Egger M; Blood; 2011 Jun; 117(23):6100-8. PubMed ID: 21368291 [TBL] [Abstract][Full Text] [Related]
11. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function. Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D; Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174 [TBL] [Abstract][Full Text] [Related]
12. [HIV-associated malignant lymphomas]. Egli F; Baumann R; Bernasconi E; Opravil M Schweiz Med Wochenschr; 1992 Apr; 122(14):495-502. PubMed ID: 1348590 [TBL] [Abstract][Full Text] [Related]
13. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience. Gray CM; Schapiro JM; Winters MA; Merigan TC AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710 [TBL] [Abstract][Full Text] [Related]
14. [Expression and diagnostic value of lymphocyte subsets and activation status in non-Hodgkin's lymphoma-associated hemophagocytic lymphohistiocytosis]. Yin GL; Wang JJ; Tian T; Duan LM; Gao X; Fang ZW; Xu J; Qiu HX; Fan L Zhonghua Xue Ye Xue Za Zhi; 2024 Aug; 45(8):748-754. PubMed ID: 39307721 [No Abstract] [Full Text] [Related]
15. Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients: a matched cohort study. Spagnuolo V; Travi G; Galli L; Cossarini F; Guffanti M; Gianotti N; Salpietro S; Lazzarin A; Castagna A Cancer; 2013 Aug; 119(15):2710-9. PubMed ID: 23625649 [TBL] [Abstract][Full Text] [Related]
16. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies. Caby F; Guiguet M; Weiss L; Winston A; Miro JM; Konopnicki D; Le Moing V; Bonnet F; Reiss P; Mussini C; Poizot-Martin I; Taylor N; Skoutelis A; Meyer L; Goujard C; Bartmeyer B; Boesecke C; Antinori A; Quiros-Roldan E; Wittkop L; Frederiksen C; Castagna A; Thurnheer MC; Svedhem V; Jose S; Costagliola D; Mary-Krause M; Grabar S; Clin Infect Dis; 2021 Jul; 73(1):50-59. PubMed ID: 34370842 [TBL] [Abstract][Full Text] [Related]
17. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy. Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients]. Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327 [TBL] [Abstract][Full Text] [Related]
19. Stem cell transplantation for lymphoma patients with HIV infection. Michieli M; Mazzucato M; Tirelli U; De Paoli P Cell Transplant; 2011; 20(3):351-70. PubMed ID: 20875226 [TBL] [Abstract][Full Text] [Related]
20. Decreased number of granzyme B+ activated CD8+ cytotoxic T lymphocytes in the inflammatory background of HIV-associated Hodgkin's lymphoma. Bosch Príncep R; Lejeune M; Salvadó Usach MT; Jaén Martínez J; Pons Ferré LE; Alvaro Naranjo T Ann Hematol; 2005 Oct; 84(10):661-6. PubMed ID: 15875183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]